Standout Papers

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance 2012 2026 2016 2021 493
  1. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance (2012)
    Peter Bouwman, Jos Jonkers Nature reviews. Cancer
  2. PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer (2019)
    Constantia Pantelidou, Olmo Sonzogni et al. Cancer Discovery

Immediate Impact

3 by Nobel laureates 22 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Understanding and targeting resistance mechanisms in cancer
2023 Standout
1 intermediate paper

Works of Peter Bouwman being referenced

Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?
2013
A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Peter Bouwman 2513 505 1110 41 3.3k
Thomas Ludwig 2482 462 1447 45 3.4k
M.L. Hooper 2906 509 1713 42 3.9k
Andreas Gast 2110 596 950 28 3.2k
Rónán C. O’Hagan 2221 326 1092 30 3.1k
Eric H. Westin 2182 630 809 65 3.6k
Karen Swisshelm 2065 586 696 60 3.1k
Joan Levy 2620 249 948 57 3.6k
Mario Cioce 2585 313 700 34 3.2k
Frederic Tort 2516 253 1313 38 3.3k
Kalindi Parmar 2116 269 843 59 3.0k

All Works

Loading papers...

Rankless by CCL
2026